Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021205

TRIZIVIR (ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE)
EQ 300MG BASE;150MG;300MG Marketing Status: Prescription

Active Ingredient: ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
Proprietary Name: TRIZIVIR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE;150MG;300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021205
Product Number: 001
Approval Date: Nov 14, 2000
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English